feed,title,long_url,short_url
Benzinga,Cassava Sciences Announces Additional Clinical Data from a Phase 2b Study of Sumifilam in Alzheimer's Disease,https://www.benzinga.com/pressreleases/20/11/g18205411/cassava-sciences-announces-additional-clinical-data-from-a-phase-2b-study-of-sumifilam-in-alzheime,https://j.mp/3k3I1G8
